Aurora's Sunrise workstation gets FDA clearance
This article was originally published in Clinica
Aurora Technology has received 510(k) clearance from the FDA to market its Sunrise diagnostic workstation in the US. The workstation is an imaging system designed specifically for high-volume review of radiological images. It has high-speed compression and zoom capabilities based on technology developed for the University of Chicago Hospitals and can review both scanned X-ray film and computed radiographs.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.